IRadimed Sees Q1 Adj. EPS $0.19-$0.21 vs $0.20 Est., Sales $10.5M-$10.7M vs $10.84M Est.; Sees FY20 Adj. EPS $0.84-$0.92 vs $0.92 Est., Sales $46.3M-$47.1M vs $46.96M Est.

Benzinga · 02/06/2020 12:49